搜尋結果
2022年11月11日 · On 16 March 2020, BioNTech and Fosun Pharma announced a strategic collaboration to develop and commercialize COVID-19 vaccines based on BioNTech's mRNA technology platform for Greater China Market including the Chinese Mainland, Hong Kong SAR, Macau SAR and Taiwan region.
2022年12月23日 · On 16 March 2020, BioNTech and Fosun Pharma announced a strategic collaboration to develop and commercialize COVID-19 vaccines based on BioNTech's mRNA technology platform for Greater China Market including Mainland China, Hong Kong Special Administrative Region and Macau Hong Kong Special Administrative Region and Taiwan region. *** About BioNTech
21 小時前 · BioNTech has established a broad set of relationships with multiple global and specialized pharmaceutical collaborators, including Biotheus, DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, Genevant, Genmab, MediLink, OncoC4, Pfizer .
2024年6月4日 · -- BioNTech and partner Shanghai Fosun Pharmaceutical delivered 11,500 doses of their mRNA-based COVID-19 vaccine to China, according to a Thursday release. The vaccines, which include omicron...
2022年11月17日 · BioNTech and Fosun Pharma Receive Emergency Use Authorization for Omicron-BA.4/BA.5 Adapted Bivalent Vaccine in Hong Kong and Special Import Authorization for Macau ... a5080b94eead475cd06.MnqXWiCCywI0_C2p9kD8fZBMJOAhmDdKCJfLJrQtQys.ATbuDEqzuFFWnn3gpATRMcInZZgWrXgjffSDc-5qE0JfQqECWuf5SneybA
2020年12月16日 · BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Sanofi, Bayer Animal Health, Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer.
3 天前 · BioNTech has established a broad set of relationships with multiple global and specialized pharmaceutical collaborators, including Biotheus, DualityBio, Fosun Pharma, Genentech, a member of the Roche Group, Genevant, Genmab, MediLink, OncoC4, Pfizer
